Veterinary Medicines

Finadyne Transdermal 50 mg/ml pour-on solution for cattle

Authorised
  • Flunixin meglumine
Download as PDF

Product identification

Medicine name:
FINIXIN TRANSDERMAL 50 mg/ml ΔΙΑΛΥΜΑ ΕΠΙΧΥΣΗΣ
Finadyne Transdermal 50 mg/ml pour-on solution for cattle
Active substance:
  • Flunixin meglumine
Target species:
  • Cattle
Route of administration:
  • Topical use

Product details

Active substance and strength:
  • Flunixin meglumine
    83.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Pour-on solution
Withdrawal period by route of administration:
  • Topical use
    • Cattle
      • Meat and offal
        7
        day
      • Milk
        36
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AG90
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:
  • High density polyethylene (HDPE) bottles with polypropylene (PP) closures which have a peelable foil laminate induction innerseal and a liner. The bottles are equipped with a graduated dosing chamber and are supplied individually in a cardboard carton.Container size: 100 ml
  • High density polyethylene (HDPE) bottles with polypropylene (PP) closures which have a peelable foil laminate induction innerseal and a liner. The bottles are equipped with a graduated dosing chamber and are supplied individually in a cardboard carton.Container size: 250 ml
  • High density polyethylene (HDPE) bottles with polypropylene (PP) closures which have a peelable foil laminate induction innerseal and a liner. The bottles are equipped with a graduated dosing chamber and are supplied individually in a cardboard carton.Container size: 1000 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Hellas A.E.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vet Pharma Friesoythe GmbH
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 68463/01-07-2020/K-0058603
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0323/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."